Leigh Zawel
Plus aucun poste en cours
Profil
Leigh Zawel worked as a Managing Director at MPM BioImpact, Inc. He was the Director of Cancer Biology at Sanofi España SA from 1999 to 2010.
From 2017 to 2022, he served as the Chief Scientific Officer-Small Molecules at Cullinan Oncology LLC and Cullinan Oncology, Inc. Zawel received his undergraduate degree from Rutgers State University of New Jersey and his graduate degree from the University of Wisconsin.
Anciens postes connus de Leigh Zawel
Sociétés | Poste | Fin |
---|---|---|
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/03/2022 |
CULLINAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2022 |
Sanofi España SA | Corporate Officer/Principal | 01/01/2010 |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | - |
Formation de Leigh Zawel
University of Wisconsin | Graduate Degree |
Rutgers State University of New Jersey | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CULLINAN THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
Sanofi España SA |